The efficacy and safety of imeglimin as add-on therapy in patientswith type 2 diabetes inadequately controlled with metformin monotherapy
- Pascale Fouqueray
- , Valdis Pirags
- , Silvio E. Inzucchi
- , Clifford J. Bailey
- , Guntram Schernthaner
- , Michaela Diamant
- , Harold E. Lebovitz
- University of Oklahoma Health Sciences Center
- Paula Stradiņa Klīniskā universitātes slimnīca
- Yale University
- Krankenanstalt Rudolfstiftung der Stadt Wien
- Vrije Universiteit Amsterdam
- Poxel SA
Research output: Contribution to journal › Article › peer-review
89
Link opens in a new tab
Citations
(Scopus)
121
Downloads
(Pure)